GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY
Published July 20, 2016 · Recall initiated: May 13, 2016
Summary
FDA records drug Class II recall D-1186-2106, published July 20, 2016 and initiated May 13, 2016. Recalling firm: Medaus, Inc.; Status: Terminated; Reported quantity: 110 mL in Vials; Lot: Lot #: 160315-14, BUD: 09/11/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Medaus, Inc.
- Distributor
- U.S. Nationwide, Japan, and New Zealand.
- Lot
- Lot #: 160315-14, BUD: 09/11/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAM.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML VialsJuly 20, 2016
- FDADEXPANTHENOL 250MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACYJuly 20, 2016
- FDAM.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 1MG; B1 0.833MG; B2 0.083MG; B3July 20, 2016
- FDAL-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACYJuly 20, 2016
- FDAFOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACYJuly 20, 2016
- FDAGERMANIUM SESO 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACYJuly 20, 2016
Questions about this recall
Was GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY recalled?
Yes. FDA published recall D-1186-2106 on July 20, 2016. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail